A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K335.6 KBAkero Therapeutics, Inc.Dec 9, 9:12 AM ET·0001140361-25-044946
- 8-K185.1 KBAkero Therapeutics, Inc.Dec 3, 10:42 AM ET·0001140361-25-044131
- 10-Q11.6 MBAkero Therapeutics, Inc.Nov 7, 5:10 PM ET·0001193125-25-272569
- 8-K899.6 KBAkero Therapeutics, Inc.Oct 9, 4:31 PM ET·0001193125-25-235919
- 8-K137.4 KBAkero Therapeutics, Inc.Sep 29, 4:05 PM ET·0001193125-25-223188
- 8-K208.9 KBAkero Therapeutics, Inc.Aug 8, 7:37 AM ET·0001193125-25-176051
- 10-Q11.8 MBAkero Therapeutics, Inc.Aug 8, 7:30 AM ET·0001193125-25-176038
- 8-K145.9 KBAkero Therapeutics, Inc.Jun 4, 4:05 PM ET·0001193125-25-134883
- 10-Q11.6 MBAkero Therapeutics, Inc.May 12, 7:30 AM ET·0000950170-25-068563
- 8-K225.5 KBAkero Therapeutics, Inc.May 12, 7:14 AM ET·0001193125-25-117287
Insiders
10- Adelman Robert J10% Owner
- Atlas Venture Associates Opportunity I, LLC10% Owner
- Atlas Venture Associates XI, LLC10% Owner
- Atlas Venture Associates XI, L.P.10% Owner
- Atlas Venture Fund XI, L.P.10% Owner
- Atlas Venture Opportunity Fund I, L.P.10% Owner
- ATP III GP, Ltd.10% Owner
- ATP Life Science Ventures, L.P.10% Owner
- Bitterman KevinDirector
- Blue Horizon Enterprise Ltd10% Owner
Tickers
No tickers on record
Addresses
business
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO, CA, 94080
mailing
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO, CA, 94080